Malaria kills around 600,000 people annually, most of them young children in Africa. Preventing malaria has long been a focus of GiveWell’s grantmaking, primarily through two proven interventions: insecticide-treated nets, which protect people while they’re sleeping, and seasonal malaria chemoprevention (SMC), which provides preventive antimalarial medicine to young children during the months when malaria transmission is highest.
As our Malaria team has grown and specialized, we’ve been able to expand beyond those two interventions. To make more progress against this disease, we recently announced plans to further scale our malaria grantmaking. As part of that effort, we’re funding monitoring and evaluation, as well as other research, to learn more about the effectiveness and potential harms of newer strategies for preventing and treating malaria. This work will help us prepare to fund the scale-up of promising and cost-effective programs in the years ahead.
In this episode, GiveWell co-founder and CEO Elie Hassenfeld speaks with three members of our Malaria research team—Senior Researcher James Watson, Senior Researcher Lucy McNamara, and Senior Program Officer Rosie Bettle—about new tools that could help prevent or treat malaria in the future.